Hypothesis

2 Matching Annotations

May 2024
aacrjournals.org aacrjournals.org

Niraparib plus Dostarlimab in Pleural Mesothelioma or Non-Small Cell Lung Cancer harboring HRR mutations: interim results of the UNITO-001 phase 2 prospective trial

2
1. scibot 23 May 2024
  
  in Public
  
  RRID:SCR_002865
  
  DOI: 10.1158/1078-0432.CCR-23-2431
  
  Resource: SPSS (RRID:SCR_002865)
  
  Curator: @abever99
  
  SciCrunch record: RRID:SCR_002865
  
  What is this?
  
  RRID:SCR_002865 DOI:10.1158/1078-0432.CCR-23-2431
2. scibot 23 May 2024
  
  in Public
  
  RRID:AB_2833074
  
  DOI: 10.1158/1078-0432.CCR-23-2431
  
  Resource: (Agilent Cat# GE00621-2, RRID:AB_2833074)
  
  Curator: @abever99
  
  SciCrunch record: RRID:AB_2833074
  
  What is this?
  
  RRID:AB_2833074 DOI:10.1158/1078-0432.CCR-23-2431
Visit annotations in context

Tags

RRID:AB_2833074

RRID:SCR_002865

DOI:10.1158/1078-0432.CCR-23-2431

Annotators

scibot

URL

aacrjournals.org/clincancerres/article/30/5/959/734303/Niraparib-plus-Dostarlimab-in-Pleural-Mesothelioma